U.S. government to buy point-of-care COVID-19 tests from Abbott, Celltrion -source

Celltrion

21/09/2021 22:10

Sept 21 (Reuters) - The U.S. government has agreed to
purchase point-of care COVID-19 tests from Abbott Laboratories
 ABT.N  and Celltrion Inc  068270.KS  to ship to nursing homes
and other high risk populations as part of its broader plan to
purchase $2 billion in rapid coronavirus tests, a person
familiar with the matter said on Tuesday. 
    The federal government will purchase tests as needed and has
agreed to spend up to $626 million in its agreement with
Celltrion and $554.4 million in its deal with Abbott, the person
said. 
    
    

 (Reporting by Carl O'Donnell
Editing by Chris Reese)
 ((Carl.ODonnell@thomsonreuters.com; 646-223-6629;))